Cara K. Fraser

867 total citations
19 papers, 591 citations indexed

About

Cara K. Fraser is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, Cara K. Fraser has authored 19 papers receiving a total of 591 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Molecular Biology and 6 papers in Epidemiology. Recurrent topics in Cara K. Fraser's work include Immune Cell Function and Interaction (4 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Herpesvirus Infections and Treatments (3 papers). Cara K. Fraser is often cited by papers focused on Immune Cell Function and Interaction (4 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Herpesvirus Infections and Treatments (3 papers). Cara K. Fraser collaborates with scholars based in Australia, United Kingdom and United States. Cara K. Fraser's co-authors include John D. Hayball, Kerrilyn R. Diener, Michael P. Brown, Tim Kuchel, Natalie E. Stevens, Timothy P. Hughes, Marianne J. Chapman, Wing Yin Tong, Erin L. Lousberg and Nicolas H. Voelcker and has published in prestigious journals such as PLoS ONE, Biomaterials and Journal of Virology.

In The Last Decade

Cara K. Fraser

19 papers receiving 581 citations

Peers

Countries citing papers authored by Cara K. Fraser

Since Specialization

Citations

This map shows the geographic impact of Cara K. Fraser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cara K. Fraser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cara K. Fraser more than expected).

Fields of papers citing papers by Cara K. Fraser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cara K. Fraser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cara K. Fraser. The network helps show where Cara K. Fraser may publish in the future.

Co-authorship network of co-authors of Cara K. Fraser

This figure shows the co-authorship network connecting the top 25 collaborators of Cara K. Fraser. A scholar is included among the top collaborators of Cara K. Fraser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cara K. Fraser. Cara K. Fraser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Neurological Examination of Sheep (Ovis aries) with Unilateral and Bilateral Quinolinic Acid Lesions of the Striatum Assessed by Magnetic Resonance Imaging 2019 ·Apollo (University of Cambridge) ·(unknown), (unknown), Timothy R. Kuchel, Sunthara Rajan Perumal, Cara K. Fraser, Kim M. Hemsley, A. Jennifer Morton	3
2	High mobility group box protein 1 neutralization therapy in ovine bacteremia: Lessons learned from an ovine septic shock model incorporating intensive care support 2019 ·Experimental and Therapeutic Medicine ·Natalie E. Stevens, (unknown), Cara K. Fraser, Tim Kuchel, Matthew J. Maiden, Marianne J. Chapman, Kerrilyn R. Diener, John D. Hayball	1
3	Adeno-Associated Virus Neutralizing Antibodies in Large Animals and Their Impact on Brain Intraparenchymal Gene Transfer 2018 ·Molecular Therapy — Methods & Clinical Development ·Dan Wang, Zhong‐Guang Li, Mengxin Li, Jia Li, Karen Tran, Lingzhi Ren, Ran He, Jun Xie, Richard P. Moser, Cara K. Fraser, Tim Kuchel, Miguel Sena‐Esteves, Terence R. Flotte, Neil Aronin, Guangping Gao	45
4	Delivery of siRNA in vitro and in vivo using PEI-capped porous silicon nanoparticles to silence MRP1 and inhibit proliferation in glioblastoma 2018 ·Journal of Nanobiotechnology ·Wing Yin Tong, (unknown), (unknown), Sinoula Apostolou, Sougata Sinha, Cara K. Fraser, Tim Kuchel, Bryone J. Kuss, Nicolas H. Voelcker	71
5	Therapeutic targeting of HMGB1 during experimental sepsis modulates the inflammatory cytokine profile to one associated with improved clinical outcomes 2017 ·Scientific Reports ·Natalie E. Stevens, Marianne J. Chapman, Cara K. Fraser, Tim Kuchel, John D. Hayball, Kerrilyn R. Diener	90
6	Metabolic profiling of presymptomatic Huntington’s disease sheep reveals novel biomarkers 2017 ·Scientific Reports ·Debra J. Skene, Benita Middleton, Cara K. Fraser, Jeroen L. A. Pennings, Timothy R. Kuchel, Skye R. Rudiger, C. Simon Bawden, A. Jennifer Morton	70
7	Preserved antiviral adaptive immunity following polyclonal antibody immunotherapy for severe murine influenza infection 2016 ·Scientific Reports ·Natalie E. Stevens, (unknown), Cara K. Fraser, Mohammed Alsharifi, Kerrilyn R. Diener, John D. Hayball	9
8	Towards a subcutaneous optical biosensor based on thermally hydrocarbonised porous silicon 2015 ·Biomaterials ·Wing Yin Tong, Martin J. Sweetman, Ezzat Marzouk, Cara K. Fraser, Tim Kuchel, Nicolas H. Voelcker	38
9	BRAF and MEK Inhibition Variably Affect GD2-specific Chimeric Antigen Receptor (CAR) T-Cell Function In Vitro 2014 ·Journal of Immunotherapy ·Tessa Gargett, Cara K. Fraser, Gianpietro Dotti, Éric Yvon, Michael P. Brown	34
10	The La antigen is over-expressed in lung cancer and is a selective dead cancer cell target for radioimmunotherapy using the La-specific antibody APOMAB® 2014 ·EJNMMI Research ·Alexander H. Staudacher, Fares Al‐Ejeh, Cara K. Fraser, Jocelyn M. Darby, David Roder, Andrew Ruszkiewicz, Jim Manavis, Michael P. Brown	22
11	An Empirical Approach towards the Efficient and Optimal Production of Influenza-Neutralizing Ovine Polyclonal Antibodies Demonstrates That the Novel Adjuvant CoVaccine HT™ Is Functionally Superior to Freund's Adjuvant 2013 ·PLoS ONE ·Natalie E. Stevens, Cara K. Fraser, Mohammed Alsharifi, Michael P. Brown, Kerrilyn R. Diener, John D. Hayball	8
12	Antigen-Specific T-Cell Responses to a Recombinant Fowlpox Virus Are Dependent on MyD88 and Interleukin-18 and Independent of Toll-Like Receptor 7 (TLR7)- and TLR9-Mediated Innate Immune Recognition 2011 ·Journal of Virology ·Erin L. Lousberg, Kerrilyn R. Diener, Cara K. Fraser, Simon Phipps, Paul S. Foster, Weisan Chen, Satoshi Uematsu, Shizuo Akira, Sarah A. Robertson, Michael P. Brown, John D. Hayball	11
13	Unravelling the complexity of cancer–immune system interplay 2010 ·Expert Review of Anticancer Therapy ·Cara K. Fraser, Michael P. Brown, Kerrilyn R. Diener, John D. Hayball	4
14	Dasatinib alters the metastatic phenotype of B16-OVA melanoma in vivo 2010 ·Cancer Biology & Therapy ·Cara K. Fraser, Erin L. Lousberg, Leigh R. Guerin, Timothy P. Hughes, Michael P. Brown, Kerrilyn R. Diener, John D. Hayball	11
15	Type I Interferons Mediate the Innate Cytokine Response to Recombinant Fowlpox Virus but Not the Induction of Plasmacytoid Dendritic Cell-Dependent Adaptive Immunity 2010 ·Journal of Virology ·Erin L. Lousberg, Cara K. Fraser, Michaël G. Tovey, Kerrilyn R. Diener, John D. Hayball	20
16	Induction of Both Cellular and Humoral Immunity following a Rational Prime-Boost Immunization Regimen That Incorporates Recombinant Ovine Atadenovirus and Fowlpox Virus 2010 ·Clinical and Vaccine Immunology ·Cara K. Fraser, Kerrilyn R. Diener, Erin L. Lousberg, Gerald W. Both, Larry D. Ward, Michael P. Brown, John D. Hayball	5
17	Dasatinib inhibits the secretion of TNF-α following TLR stimulation in vitro and in vivo 2009 ·Experimental Hematology ·Cara K. Fraser, Erin L. Lousberg, Raman Kumar, Timothy P. Hughes, Kerrilyn R. Diener, John D. Hayball	38
18	Dasatinib inhibits recombinant viral antigen-specific murine CD4+ and CD8+ T-cell responses and NK-cell cytolytic activity in vitro and in vivo 2008 ·Experimental Hematology ·Cara K. Fraser, Stephen J. Blake, Kerrilyn R. Diener, A. Bruce Lyons, Michael P. Brown, Timothy P. Hughes, John D. Hayball	50
19	Improving vaccines by incorporating immunological coadjuvants 2007 ·Expert Review of Vaccines ·Cara K. Fraser, Kerrilyn R. Diener, Michael P. Brown, John D. Hayball	61

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact